Leanne Talbot, Author at Neuroendocrine Cancer UK

May Highlights!

by Leanne Talbot | May 10, 2024

Thanks to you, this is what we have been able to achieve this month. – https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2024/07/SM-ROUNDUP-VIDEO-7.mp4 – 🎉 May Highlights! 🎉 📰 We were thrilled to announce that NICE has recommended SIRT...

OPEN Health Want to Hear from You – Research Study

by Leanne Talbot | May 1, 2024

OPEN Health are conducting interviews to understand the experiences of people living with neuroendocrine tumours of the gastrointestinal system and pancreas (GEP-NETs). Select here to download the PDF.

New screening programme identifies clinical trial opportunities for neuroendocrine cancer patients

by Leanne Talbot | Apr 30, 2024

– We are often told by our community that it is difficult to find information on clinical trials, and that the information around clinical trials can be difficult to interpret and understand if you don’t have a scientific or medical background. Even when...

Rarecan Seeks Your Input on Genetic Analysis Services

by Leanne Talbot | Apr 10, 2024

Rarecan, in collaboration with its partners, is exploring the potential for offering genetic analysis services to aid in cancer treatment decisions and clinical trial eligibility. Advancements in technology have made genetic analysis of tumors increasingly...

Pancreatic Enzyme Replacement Therapy (PERT) Update – Creon®, Nutrizym® and Pancrex®.

by Leanne Talbot | Apr 5, 2024

Pancreatic Enzyme Replacement Therapy (PERT) – product brands: Creon®, Nutrizym® and Pancrex®. Many of you are aware that there has been some variability and inconsistency in the delivery and availability, at local level, of PERT. This has led to some people...

May Highlights!

OPEN Health Want to Hear from You – Research Study

New screening programme identifies clinical trial opportunities for neuroendocrine cancer patients

Rarecan Seeks Your Input on Genetic Analysis Services

Pancreatic Enzyme Replacement Therapy (PERT) Update – Creon®, Nutrizym® and Pancrex®.

About Us

Subscribe

Contact

Helpline: 0800 434 6476

Office: 01926 883 487

Holly House, 74 Upper Holly Walk, Leamington Spa CV32 4JL

Email us